These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 14693976)

  • 1. The performance of a risk score as a screening test for undiagnosed hyperglycemia in ethnic minority groups: data from the 1999 health survey for England.
    Spijkerman AM; Yuyun MF; Griffin SJ; Dekker JM; Nijpels G; Wareham NJ
    Diabetes Care; 2004 Jan; 27(1):116-22. PubMed ID: 14693976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The performance of a risk score in predicting undiagnosed hyperglycemia.
    Park PJ; Griffin SJ; Sargeant L; Wareham NJ
    Diabetes Care; 2002 Jun; 25(6):984-8. PubMed ID: 12032103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal cut-off points of fasting plasma glucose for two-step strategy in estimating prevalence and screening undiagnosed diabetes and pre-diabetes in Harbin, China.
    Bao C; Zhang D; Sun B; Lan L; Cui W; Xu G; Sui C; Wang Y; Zhao Y; Wang J; Li H
    PLoS One; 2015; 10(3):e0119510. PubMed ID: 25785585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation and validation of diabetes risk score for urban Asian Indians.
    Ramachandran A; Snehalatha C; Vijay V; Wareham NJ; Colagiuri S
    Diabetes Res Clin Pract; 2005 Oct; 70(1):63-70. PubMed ID: 16126124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the CANRISK tool in the identification of dysglycemia in a Canadian South Asian Population.
    Agarwal G; Jiang Y; Lemieux C; Rogers Van Katwyk S; Mao Y; Orpana H; Fong M; Morrison H
    Health Promot Chronic Dis Prev Can; 2018; 38(7-8):287-294. PubMed ID: 30129716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cut-off points of fasting fingertip capillary blood glucose for detecting both undiagnosed diabetes and pre-diabetes].
    Zhang YL; Guo SQ; Ma WB; Wang J; Bai GQ; Yang Q; Ti SF; Ma R; Wei RP; Liu WX; Li Z; Yang L; Liu DW; Li ZH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Oct; 31(10):1174-8. PubMed ID: 21162825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of the CANRISK tool in the identification of dysglycemia in First Nations and Métis in Canada.
    Agarwal G; Jiang Y; Rogers Van Katwyk S; Lemieux C; Orpana H; Mao Y; Hanley B; Davis K; Leuschen L; Morrison H
    Health Promot Chronic Dis Prev Can; 2018 Feb; 38(2):55-63. PubMed ID: 29443485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
    Salinero-Fort MA; Burgos-Lunar C; Lahoz C; Mostaza JM; Abánades-Herranz JC; Laguna-Cuesta F; Estirado-de Cabo E; García-Iglesias F; González-Alegre T; Fernández-Puntero B; Montesano-Sánchez L; Vicent-López D; Cornejo-Del Río V; Fernández-García PJ; Sánchez-Arroyo V; Sabín-Rodríguez C; López-López S; Patrón-Barandio P; Gómez-Campelo P;
    PLoS One; 2016; 11(7):e0158489. PubMed ID: 27441722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a Diabetes Risk Score for screening undiagnosed diabetes in Sri Lanka (SLDRISK).
    Katulanda P; Hill NR; Stratton I; Sheriff R; De Silva SD; Matthews DR
    BMC Endocr Disord; 2016 Jul; 16(1):42. PubMed ID: 27456082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of clinical scores to detect dysglycaemia in overweight or obese women.
    Cosson E; Chiheb S; Hamo-Tchatchouang E; Nguyen MT; Aout M; Banu I; Pillegand C; Vicaut E; Valensi P
    Diabetes Metab; 2012 Jun; 38(3):217-24. PubMed ID: 22300975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000.
    Rathmann W; Martin S; Haastert B; Icks A; Holle R; Löwel H; Giani G;
    Arch Intern Med; 2005 Feb; 165(4):436-41. PubMed ID: 15738374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a screening tool using electronic health records for undiagnosed Type 2 diabetes mellitus and impaired fasting glucose detection in the Slovenian population.
    Štiglic G; Kocbek P; Cilar L; Fijačko N; Stožer A; Zaletel J; Sheikh A; Povalej Bržan P
    Diabet Med; 2018 May; 35(5):640-649. PubMed ID: 29460977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Chinese risk score model for identifying postprandial hyperglycemia without oral glucose tolerance test.
    Fu Q; Sun M; Tang W; Wang Z; Cao M; Zhu Z; Lu L; Bi Y; Ning G; Yang T
    Diabetes Metab Res Rev; 2014 May; 30(4):284-90. PubMed ID: 24154991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resting heart rate as a marker for identifying the risk of undiagnosed type 2 diabetes mellitus: a cross-sectional survey.
    Li YQ; Sun CQ; Li LL; Wang L; Guo YR; You AG; Xi YL; Wang CJ
    BMC Public Health; 2014 Oct; 14():1052. PubMed ID: 25297916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a clinical guideline to predict undiagnosed diabetes in dental patients.
    Li S; Williams PL; Douglass CW
    J Am Dent Assoc; 2011 Jan; 142(1):28-37. PubMed ID: 21193764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting cut-points in determining prevalence of diabetes in an Arab population of the Middle East.
    Al-Lawati JA; Barakat MN
    Diabetes Res Clin Pract; 2007 Feb; 75(2):241-5. PubMed ID: 16875755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol.
    Salinero-Fort MÁ; de Burgos-Lunar C; Mostaza Prieto J; Lahoz Rallo C; Abánades-Herranz JC; Gómez-Campelo P; Laguna Cuesta F; Estirado De Cabo E; García Iglesias F; González Alegre T; Fernández Puntero B; Montesano Sánchez L; Vicent López D; Cornejo Del Río V; Fernández García PJ; Sabín Rodríguez C; López López S; Patrón Barandío P;
    BMJ Open; 2015 Jul; 5(7):e007195. PubMed ID: 26220868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Colombian diabetes risk score for detecting undiagnosed diabetes and impaired glucose regulation.
    Barengo NC; Tamayo DC; Tono T; Tuomilehto J
    Prim Care Diabetes; 2017 Feb; 11(1):86-93. PubMed ID: 27727004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting.
    Gray LJ; Taub NA; Khunti K; Gardiner E; Hiles S; Webb DR; Srinivasan BT; Davies MJ
    Diabet Med; 2010 Aug; 27(8):887-95. PubMed ID: 20653746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes risk score in Oman: a tool to identify prevalent type 2 diabetes among Arabs of the Middle East.
    Al-Lawati JA; Tuomilehto J
    Diabetes Res Clin Pract; 2007 Sep; 77(3):438-44. PubMed ID: 17306410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.